The aim of the paper was to describe a new formula (Antilip®) consisting of very low dosages of polyglucosamine, phytosterols and Monascus purpureus. It was given to subjects affected by high cholesterol levels.
Antilip®: treatment of subjects with high total cholesterol tolerability and efficacy in a short-term registry study / M.R. Cesarone, A. Ledda, G. Belcaro, A. Ricci, S. Stuard, L. Pellegrini, E. Ippolito, U. Cornelli. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - 52:2 Suppl 1(2010 Jun), pp. 15-19.
Antilip®: treatment of subjects with high total cholesterol tolerability and efficacy in a short-term registry study
E. IppolitoPenultimo
;
2010
Abstract
The aim of the paper was to describe a new formula (Antilip®) consisting of very low dosages of polyglucosamine, phytosterols and Monascus purpureus. It was given to subjects affected by high cholesterol levels.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
